Verici Dx Share Discussion Threads

[toffeeman] 24/11/2023 16:35

I think that VRCI and GENI are suffering from RENX disease

[bmcollins] 24/11/2023 16:24

Well after the excellent investor presentation on Wednesday pm who would have thought we would be at 9p to 9.5p just before the close, yes I have added, I just wonder why buyers appear here to be as rare as rocking horse manure ?

[petejay] 16/11/2023 08:40

Good write up in Daily Mail market report today News is getting out there

[brummy_git] 16/11/2023 08:25

In this fascinating interview CEO Sara Barrington of Verici Dx - a developer of advanced clinical diagnostics for organ transplant - kindly takes me through yesterday's transformational licensing & commercialisation agreement with life sciences giant Thermo Fisher Scientific.

Here explaining how the relationship will work, the companies' joint long term vision and importantly what synergistic services each party will bring to this hugely significant deal.

[baker783] 15/11/2023 13:05

Over 9m shares which were distributed to EKF holders in summer are unlocked. That is the seller(s)

[seadog40] 15/11/2023 12:38

On the 5th October conf call they said that the cash runway was unchanged at "mid 2024".
How come they now are forecast to have only $100k at year end 2023??

[wan] 15/11/2023 11:04

From my post 565 3rd October -

I am also more than intrigued by Verici stating that they will be assessing the role of urine-based testing as part of their research and product development opportunities based on their clinical trial samples and data.

However, we have not been guided that Verici has a urine-based test (in development or otherwise), but I am aware of a very large company that has a urine-based transplant test in development. In any regard, there are clearly companies where Verici's clinical trial samples and data will provide a very valuable resource in terms of research and product development.
(END)

Thermo Fisher and their urine-based test in development was what I was referring to -

FEBRUARY 22, 2022
BIO-TECHNE ANNOUNCES EXCLUSIVE DEVELOPMENT AND LICENSE AGREEMENT WITH THERMO FISHER SCIENTIFIC FOR EXOTRU® KIDNEY TRANSPLANT REJECTION ASSAY




So, one assumes Verici'c urine-based clinical trial samples could also be of interest in the development of Thermo's ExoTRU non-invasive multigene urine-based liquid biopsy assay (and not just for the pre-transplant test).

What we don't yet know is how far Thermo will take development, because they have "the sole right, but not obligation, to manufacture, distribute and sell the assay worldwide"

Apparently, Verici is now forecast to end 2023 with net cash of $0.1m. (less than a £100k), with the forecast for 2024 turnover increased to $8.6m. So in my view, it still looks like a capital raise will be required as they are burning through around $10m per annum.

[firestarter1] 15/11/2023 08:38

When was the last placing would be silly not to raise

[babbler] 15/11/2023 08:21

Non exclusive deal too IE others could flow now...

[brummy_git] 15/11/2023 08:19

Blockbuster licensing deal announced today by expert immunodiagnostics firm Verici Dx
Mrkcap £10m) with Thermo Fisher


All the details here.

[adorling] 15/11/2023 08:18

Game changer of an RNS!

[wan] 15/11/2023 08:01

Clearly, Thermo is a very large global player!

[multibagger] 15/11/2023 07:19

Good morning all :)

An exciting commercialisation partner Thermo Fisher with $5m in 12 months for starters.....good luck all !
Should add some zest to the share price today !

[cliveas] 15/11/2023 07:19

Nice Jv bringing in $5m with further benefits.

For me this only has to be the start of the money rollercoaster that VRCI are going to create.

Literally they are taking the urine!

'In addition, Verici Dx has granted Thermo Fisher a non-exclusive license for access to a portion of the Company's urine samples, demonstrating the additional value in the Company's data and sample assets for research.'

They were already fully funded until mid 2024 so no placings ahoy!

GL.

[sirshagalot] 13/11/2023 11:21

I am not selling in fact when timing right i will buy more, "bottom feeding" is a fine art.
DYOR and good luck to all holders.

[adorling] 10/11/2023 16:54

Down 11.5% despite 370,000 buys and 56,000 sells today?

[adorling] 10/11/2023 16:49

Looks like we still have a big seller - is that you Wan as my buy orders were filled with no problems and that is unusual?

[sirshagalot] 10/11/2023 12:15

God i am tempeted lol!
There will be some sort of rebound i should imagine,but i have my own rules they must drop over a certain percenatage to justify another bite.

[adorling] 10/11/2023 12:07

Just added another 100,000 at 6.08p

[riskblue] 10/11/2023 09:35

Risk of being taken out cheaply?

[wan] 03/10/2023 13:10

I am also more than intrigued by Verici stating that they will be assessing the role of urine-based testing as part of their research and product development opportunities based on their clinical trial samples and data.

However, we have not been guided that Verici has a urine-based test (in development or otherwise), but I am aware of a very large company that has a urine-based transplant test in development. In any regard, there are clearly companies where Verici's clinical trial samples and data will provide a very valuable resource in terms of research and product development.